APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucokinase

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glucokinase Industry Growth and Trends Forecast to 2032

5 July 202692 pages

Choose your research edition.

Industry ResearchGlucokinase Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucokinase Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Glucokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucokinase Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucokinase Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Glucokinase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucokinase include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc and Yuhan Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glucokinase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucokinase market size, estimates, and forecasts are presented in terms of sales volume (kt) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucokinase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucokinase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glucokinase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucokinase Market by Company

Amgen Inc

Eli Lilly and Co

Ligand Pharmaceuticals Inc

Merck & Co Inc

Poxel SA

Teijin Pharma Ltd

vTv Therapeutics Inc

Yuhan Corp

Glucokinase Segment by Type

LY-2608204

Sinogliatin

AM-9514

TMG-123

TTP-399

Others

Glucokinase Segment by Application

Metabolic Disorder

Obesity

Diabetes

Others

Glucokinase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucokinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucokinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glucokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of LY-2608204 Table 2. Major Company of Sinogliatin Table 3. Major Company of AM-9514 Table 4. Major Company of TMG-123 Table 5. Major Company of TTP-399 Table 6. Major Company of Others Table 7. Global Glucokinase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Glucokinase Sales by Type (2021-2026) & (kt) Table 9. Global Glucokinase Sales Market Share in Volume by Type (2021-2026) Table 10. Global Glucokinase Sales by Type (2021-2026) & (US$ Million) Table 11. Global Glucokinase Sales Market Share in Value by Type (2021-2026) Table 12. Global Glucokinase Price by Type (2021-2026) & (USD/t) Table 13. Global Glucokinase Sales by Type (2027-2032) & (kt) Table 14. Global Glucokinase Sales Market Share in Volume by Type (2027-2032) Table 15. Global Glucokinase Sales by Type (2027-2032) & (US$ Million) Table 16. Global Glucokinase Sales Market Share in Value by Type (2027-2032) Table 17. Global Glucokinase Price by Type (2027-2032) & (USD/t) Table 18. North America Glucokinase Sales by Type (2021-2026) & (kt) Table 19. North America Glucokinase Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Glucokinase Sales by Type (2021-2026) & (kt) Table 21. Europe Glucokinase Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Glucokinase Sales by Type (2021-2026) & (kt) Table 23. Asia-Pacific Glucokinase Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Glucokinase Sales by Type (2021-2026) & (kt) Table 25. Latin America Glucokinase Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Glucokinase Sales by Type (2021-2026) & (kt) Table 27. Middle East and Africa Glucokinase Sales by Type (2021-2026) & (US$ Million) Table 28. Glucokinase Industry Trends Table 29. Glucokinase Industry Drivers Table 30. Glucokinase Industry Opportunities and Challenges Table 31. Glucokinase Industry Restraints Table 32. Global Glucokinase Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Glucokinase Revenue Market Share by Company (2021-2026) Table 34. Global Glucokinase Sales by Company (2021-2026) & (kt) Table 35. Global Glucokinase Sales Share by Company (2021-2026) Table 36. Global Glucokinase Market Price by Company (2021-2026) & (USD/t) Table 37. Global Glucokinase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Glucokinase Major Company Production Sites and Headquarters Table 39. Global Glucokinase Company, Product Type & Application Table 40. Global Glucokinase Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Glucokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Glucokinase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Glucokinase Sales by Region (2021-2026) & (kt) Table 45. Global Glucokinase Sales Market Share in Volume by Region (2021-2026) Table 46. Global Glucokinase Sales by Region (2021-2026) & (US$ Million) Table 47. Global Glucokinase Sales Market Share in Value by Region (2021-2026) Table 48. Global Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 49. Global Glucokinase Sales by Region (2027-2032) & (kt) Table 50. Global Glucokinase Sales Market Share in Volume by Region (2027-2032) Table 51. Global Glucokinase Sales by Region (2027-2032) & (US$ Million) Table 52. Global Glucokinase Sales Market Share in Value by Region (2027-2032) Table 53. Global Glucokinase Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 54. Global Glucokinase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Glucokinase Sales by Application (2021-2026) & (kt) Table 56. Global Glucokinase Sales Market Share in Volume by Application (2021-2026) Table 57. Global Glucokinase Sales by Application (2021-2026) & (US$ Million) Table 58. Global Glucokinase Sales Market Share in Value by Application (2021-2026) Table 59. Global Glucokinase Price by Application (2021-2026) & (USD/t) Table 60. Global Glucokinase Sales by Application (2027-2032) & (kt) Table 61. Global Glucokinase Sales Market Share in Volume by Application (2027-2032) Table 62. Global Glucokinase Sales by Application (2027-2032) & (US$ Million) Table 63. Global Glucokinase Sales Market Share in Value by Application (2027-2032) Table 64. Global Glucokinase Price by Application (2027-2032) & (USD/t) Table 65. North America Glucokinase Sales by Application (2021-2026) & (kt) Table 66. North America Glucokinase Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Glucokinase Sales by Application (2021-2026) & (kt) Table 68. Europe Glucokinase Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Glucokinase Sales by Application (2021-2026) & (kt) Table 70. Asia-Pacific Glucokinase Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Glucokinase Sales by Application (2021-2026) & (kt) Table 72. Latin America Glucokinase Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Glucokinase Sales by Application (2021-2026) & (kt) Table 74. Middle East and Africa Glucokinase Sales by Application (2021-2026) & (US$ Million) Table 75. Amgen Inc Company Information Table 76. Amgen Inc Business Overview Table 77. Amgen Inc Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Amgen Inc Glucokinase Product Portfolio Table 79. Amgen Inc Recent Development Table 80. Eli Lilly and Co Company Information Table 81. Eli Lilly and Co Business Overview Table 82. Eli Lilly and Co Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Eli Lilly and Co Glucokinase Product Portfolio Table 84. Eli Lilly and Co Recent Development Table 85. Ligand Pharmaceuticals Inc Company Information Table 86. Ligand Pharmaceuticals Inc Business Overview Table 87. Ligand Pharmaceuticals Inc Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Ligand Pharmaceuticals Inc Glucokinase Product Portfolio Table 89. Ligand Pharmaceuticals Inc Recent Development Table 90. Merck & Co Inc Company Information Table 91. Merck & Co Inc Business Overview Table 92. Merck & Co Inc Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Merck & Co Inc Glucokinase Product Portfolio Table 94. Merck & Co Inc Recent Development Table 95. Poxel SA Company Information Table 96. Poxel SA Business Overview Table 97. Poxel SA Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Poxel SA Glucokinase Product Portfolio Table 99. Poxel SA Recent Development Table 100. Teijin Pharma Ltd Company Information Table 101. Teijin Pharma Ltd Business Overview Table 102. Teijin Pharma Ltd Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Teijin Pharma Ltd Glucokinase Product Portfolio Table 104. Teijin Pharma Ltd Recent Development Table 105. vTv Therapeutics Inc Company Information Table 106. vTv Therapeutics Inc Business Overview Table 107. vTv Therapeutics Inc Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. vTv Therapeutics Inc Glucokinase Product Portfolio Table 109. vTv Therapeutics Inc Recent Development Table 110. Yuhan Corp Company Information Table 111. Yuhan Corp Business Overview Table 112. Yuhan Corp Glucokinase Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Yuhan Corp Glucokinase Product Portfolio Table 114. Yuhan Corp Recent Development Table 115. North America Glucokinase Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 116. North America Glucokinase Sales by Country (2021-2026) & (kt) Table 117. North America Glucokinase Sales Market Share by Country (2021-2026) Table 118. North America Glucokinase Sales Forecast by Country (2027-2032) & (kt) Table 119. North America Glucokinase Sales Market Share Forecast by Country (2027-2032) Table 120. North America Glucokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Glucokinase Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Glucokinase Market Share by Country (2021-2026) Table 123. North America Glucokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Glucokinase Market Share Forecast by Country (2027-2032) Table 125. Europe Glucokinase Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 126. Europe Glucokinase Sales by Country (2021-2026) & (kt) Table 127. Europe Glucokinase Sales Market Share by Country (2021-2026) Table 128. Europe Glucokinase Sales Forecast by Country (2027-2032) & (kt) Table 129. Europe Glucokinase Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Glucokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Glucokinase Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Glucokinase Market Share by Country (2021-2026) Table 133. Europe Glucokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Glucokinase Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Glucokinase Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Glucokinase Sales by Country (2021-2026) & (kt) Table 137. Asia-Pacific Glucokinase Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Glucokinase Sales Forecast by Country (2027-2032) & (kt) Table 139. Asia-Pacific Glucokinase Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Glucokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Glucokinase Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Glucokinase Market Share by Country (2021-2026) Table 143. Asia-Pacific Glucokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Glucokinase Market Share Forecast by Country (2027-2032) Table 145. Latin America Glucokinase Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 146. Latin America Glucokinase Sales by Country (2021-2026) & (kt) Table 147. Latin America Glucokinase Sales Market Share by Country (2021-2026) Table 148. Latin America Glucokinase Sales Forecast by Country (2027-2032) & (kt) Table 149. Latin America Glucokinase Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Glucokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Glucokinase Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Glucokinase Market Share by Country (2021-2026) Table 153. Latin America Glucokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Glucokinase Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Glucokinase Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Glucokinase Sales by Country (2021-2026) & (kt) Table 157. Middle East and Africa Glucokinase Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Glucokinase Sales Forecast by Country (2027-2032) & (kt) Table 159. Middle East and Africa Glucokinase Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Glucokinase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Glucokinase Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Glucokinase Market Share by Country (2021-2026) Table 163. Middle East and Africa Glucokinase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Glucokinase Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Glucokinase Distributors List Table 168. Glucokinase Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Glucokinase Image Figure 2. Global Glucokinase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucokinase Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucokinase Sales (2021-2032) & (kt) Figure 5. LY-2608204 Image Figure 6. Global LY-2608204 Sales YoY Growth (2021-2032) & (kt) Figure 7. Sinogliatin Image Figure 8. Global Sinogliatin Sales YoY Growth (2021-2032) & (kt) Figure 9. AM-9514 Image Figure 10. Global AM-9514 Sales YoY Growth (2021-2032) & (kt) Figure 11. TMG-123 Image Figure 12. Global TMG-123 Sales YoY Growth (2021-2032) & (kt) Figure 13. TTP-399 Image Figure 14. Global TTP-399 Sales YoY Growth (2021-2032) & (kt) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (kt) Figure 17. Global Glucokinase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Glucokinase Market Share by Type 2025 VS 2032 Figure 19. North America Glucokinase Sales Market Share in Volume by Type in 2025 Figure 20. North America Glucokinase Sales Market Share in Value by Type in 2025 Figure 21. Europe Glucokinase Sales Market Share in Volume by Type in 2025 Figure 22. Europe Glucokinase Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Glucokinase Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Glucokinase Sales Market Share in Value by Type in 2025 Figure 25. Latin America Glucokinase Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Glucokinase Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Glucokinase Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Glucokinase Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Glucokinase Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Metabolic Disorder Image Figure 32. Global Metabolic Disorder Sales YoY Growth (2021-2032) & (kt) Figure 33. Obesity Image Figure 34. Global Obesity Sales YoY Growth (2021-2032) & (kt) Figure 35. Diabetes Image Figure 36. Global Diabetes Sales YoY Growth (2021-2032) & (kt) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (kt) Figure 39. Global Glucokinase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Glucokinase Market Share by Application 2025 VS 2032 Figure 41. North America Glucokinase Sales Market Share in Volume by Application in 2025 Figure 42. North America Glucokinase Sales Market Share in Value by Application in 2025 Figure 43. Europe Glucokinase Sales Market Share in Volume by Application in 2025 Figure 44. Europe Glucokinase Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Glucokinase Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Glucokinase Sales Market Share in Value by Application in 2025 Figure 47. Latin America Glucokinase Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Glucokinase Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Glucokinase Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Glucokinase Sales Market Share in Value by Application in 2025 Figure 51. North America Glucokinase Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 52. North America Glucokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Glucokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Glucokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Glucokinase Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 56. Europe Glucokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Glucokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Glucokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Glucokinase Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 60. Asia-Pacific Glucokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Glucokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Glucokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Glucokinase Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 64. Latin America Glucokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Glucokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Glucokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Glucokinase Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 68. Middle East and Africa Glucokinase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Glucokinase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Glucokinase Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Glucokinase Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Glucokinase Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • LY-2608204
  • Sinogliatin
  • AM-9514
  • TMG-123
  • TTP-399
  • Others
Applications
  • Metabolic Disorder
  • Obesity
  • Diabetes
  • Others
Companies covered
  • Amgen Inc
  • Eli Lilly and Co
  • Ligand Pharmaceuticals Inc
  • Merck & Co Inc
  • Poxel SA
  • Teijin Pharma Ltd
  • vTv Therapeutics Inc
  • Yuhan Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucokinase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glucokinase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glucokinase Market by Type
  6. 1.3.1 LY-2608204
  7. 1.3.2 Sinogliatin
  8. 1.3.3 AM-9514
  9. 1.3.4 TMG-123
  10. 1.3.5 TTP-399
  11. 1.3.6 Others
  12. 1.4 Global Glucokinase Market Size by Type
  13. 1.4.1 Global Glucokinase Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Glucokinase Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Glucokinase Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Glucokinase Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Glucokinase Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Glucokinase Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Glucokinase Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Glucokinase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glucokinase Industry Trends
  2. 2.2 Glucokinase Industry Drivers
  3. 2.3 Glucokinase Industry Opportunities and Challenges
  4. 2.4 Glucokinase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glucokinase Revenue (2021-2026)
  2. 3.2 Global Top Players by Glucokinase Sales (2021-2026)
  3. 3.3 Global Top Players by Glucokinase Price (2021-2026)
  4. 3.4 Global Glucokinase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucokinase Major Company Production Sites & Headquarters
  6. 3.6 Global Glucokinase Company, Product Type & Application
  7. 3.7 Global Glucokinase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucokinase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucokinase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucokinase Tier 1, Tier 2, and Tier 3
4 Glucokinase Regional Status and Outlook
  1. 4.1 Global Glucokinase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glucokinase Historic Market Size by Region
  3. 4.2.1 Global Glucokinase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glucokinase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glucokinase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glucokinase Forecasted Market Size by Region
  7. 4.3.1 Global Glucokinase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glucokinase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glucokinase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glucokinase by Application
  1. 5.1 Glucokinase Market by Application
  2. 5.1.1 Metabolic Disorder
  3. 5.1.2 Obesity
  4. 5.1.3 Diabetes
  5. 5.1.4 Others
  6. 5.2 Global Glucokinase Market Size by Application
  7. 5.2.1 Global Glucokinase Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Glucokinase Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Glucokinase Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Glucokinase Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Glucokinase Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Glucokinase Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Glucokinase Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Glucokinase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen Inc
  2. 6.1.1 Amgen Inc Company Information
  3. 6.1.2 Amgen Inc Business Overview
  4. 6.1.3 Amgen Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen Inc Glucokinase Product Portfolio
  6. 6.1.5 Amgen Inc Recent Developments
  7. 6.2 Eli Lilly and Co
  8. 6.2.1 Eli Lilly and Co Company Information
  9. 6.2.2 Eli Lilly and Co Business Overview
  10. 6.2.3 Eli Lilly and Co Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly and Co Glucokinase Product Portfolio
  12. 6.2.5 Eli Lilly and Co Recent Developments
  13. 6.3 Ligand Pharmaceuticals Inc
  14. 6.3.1 Ligand Pharmaceuticals Inc Company Information
  15. 6.3.2 Ligand Pharmaceuticals Inc Business Overview
  16. 6.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Portfolio
  18. 6.3.5 Ligand Pharmaceuticals Inc Recent Developments
  19. 6.4 Merck & Co Inc
  20. 6.4.1 Merck & Co Inc Company Information
  21. 6.4.2 Merck & Co Inc Business Overview
  22. 6.4.3 Merck & Co Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co Inc Glucokinase Product Portfolio
  24. 6.4.5 Merck & Co Inc Recent Developments
  25. 6.5 Poxel SA
  26. 6.5.1 Poxel SA Company Information
  27. 6.5.2 Poxel SA Business Overview
  28. 6.5.3 Poxel SA Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Poxel SA Glucokinase Product Portfolio
  30. 6.5.5 Poxel SA Recent Developments
  31. 6.6 Teijin Pharma Ltd
  32. 6.6.1 Teijin Pharma Ltd Company Information
  33. 6.6.2 Teijin Pharma Ltd Business Overview
  34. 6.6.3 Teijin Pharma Ltd Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Teijin Pharma Ltd Glucokinase Product Portfolio
  36. 6.6.5 Teijin Pharma Ltd Recent Developments
  37. 6.7 vTv Therapeutics Inc
  38. 6.7.1 vTv Therapeutics Inc Company Information
  39. 6.7.2 vTv Therapeutics Inc Business Overview
  40. 6.7.3 vTv Therapeutics Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 vTv Therapeutics Inc Glucokinase Product Portfolio
  42. 6.7.5 vTv Therapeutics Inc Recent Developments
  43. 6.8 Yuhan Corp
  44. 6.8.1 Yuhan Corp Company Information
  45. 6.8.2 Yuhan Corp Business Overview
  46. 6.8.3 Yuhan Corp Glucokinase Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Yuhan Corp Glucokinase Product Portfolio
  48. 6.8.5 Yuhan Corp Recent Developments
7 North America by Country
  1. 7.1 North America Glucokinase Sales by Country
  2. 7.1.1 North America Glucokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glucokinase Sales by Country (2021-2026)
  4. 7.1.3 North America Glucokinase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glucokinase Market Size by Country
  6. 7.2.1 North America Glucokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glucokinase Market Size by Country (2021-2026)
  8. 7.2.3 North America Glucokinase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glucokinase Sales by Country
  2. 8.1.1 Europe Glucokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glucokinase Sales by Country (2021-2026)
  4. 8.1.3 Europe Glucokinase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glucokinase Market Size by Country
  6. 8.2.1 Europe Glucokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glucokinase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glucokinase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glucokinase Sales by Country
  2. 9.1.1 Asia-Pacific Glucokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glucokinase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glucokinase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glucokinase Market Size by Country
  6. 9.2.1 Asia-Pacific Glucokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glucokinase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glucokinase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glucokinase Sales by Country
  2. 10.1.1 South America Glucokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glucokinase Sales by Country (2021-2026)
  4. 10.1.3 South America Glucokinase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glucokinase Market Size by Country
  6. 10.2.1 South America Glucokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glucokinase Market Size by Country (2021-2026)
  8. 10.2.3 South America Glucokinase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glucokinase Sales by Country
  2. 11.1.1 Middle East and Africa Glucokinase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glucokinase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glucokinase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glucokinase Market Size by Country
  6. 11.2.1 Middle East and Africa Glucokinase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glucokinase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glucokinase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glucokinase Value Chain Analysis
  2. 12.1.1 Glucokinase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glucokinase Production Mode & Process
  7. 12.2 Glucokinase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glucokinase Distributors
  10. 12.2.3 Glucokinase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst